HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Laura Dugo Selected Research

Rosiglitazone (Avandia)

5/2004Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-gamma, reduces acute pancreatitis induced by cerulein.
2/2004Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-gamma, reduces the development of nonseptic shock induced by zymosan in mice.
1/2004Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-gamma, reduces acute inflammation.
12/2003Reduction in the evolution of murine type II collagen-induced arthritis by treatment with rosiglitazone, a ligand of the peroxisome proliferator-activated receptor gamma.
9/2003Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2, ligands of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), reduce ischaemia/reperfusion injury of the gut.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Laura Dugo Research Topics

Disease

27Inflammation (Inflammations)
03/2022 - 01/2002
14Shock
02/2007 - 03/2002
11Necrosis
03/2004 - 01/2002
7Pleurisy (Pleuritis)
08/2004 - 01/2002
6Lung Injury
03/2004 - 01/2002
5Experimental Arthritis
07/2006 - 01/2002
4Ischemia
02/2007 - 08/2002
4Body Weight (Weight, Body)
10/2004 - 10/2002
4Pancreatitis
05/2004 - 05/2002
3Neoplasms (Cancer)
03/2022 - 01/2012
3Sepsis (Septicemia)
01/2007 - 09/2005
3Arthritis (Polyarthritis)
07/2006 - 10/2002
3Hemorrhage
05/2006 - 05/2002
3Multiple Organ Failure (MODS)
10/2004 - 10/2002
3Edema (Dropsy)
05/2004 - 05/2002
3Colitis
04/2004 - 07/2002
3Reperfusion Injury
09/2003 - 01/2002
2Colorectal Neoplasms (Colorectal Cancer)
03/2022 - 08/2011
2Bone Resorption
06/2017 - 10/2002
2Type 2 Diabetes Mellitus (MODY)
06/2017 - 01/2015
2Septic Shock (Toxic Shock Syndrome)
02/2007 - 09/2004
2Endotoxemia
09/2005 - 03/2004
2Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
02/2003 - 07/2002
2Weight Loss (Weight Reduction)
02/2003 - 07/2002
1Cardiovascular Diseases (Cardiovascular Disease)
03/2022
1Adenocarcinoma
03/2020
1Breast Neoplasms (Breast Cancer)
03/2020
1Infertility (Sterility)
02/2020
1Bacterial Infections (Bacterial Infection)
02/2020

Drug/Important Bio-Agent (IBA)

11CarrageenanIBA
08/2004 - 01/2002
8PPAR gammaIBA
09/2004 - 05/2002
7CytokinesIBA
03/2022 - 06/2002
7LigandsIBA
09/2004 - 09/2003
6CreatinineIBA
05/2006 - 08/2002
6Lipase (Acid Lipase)FDA Link
09/2005 - 05/2002
6Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
10/2004 - 01/2002
6Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
03/2004 - 01/2002
5Aspartate Aminotransferases (Aspartate Transaminase)IBA
05/2006 - 03/2003
5ZymosanIBA
10/2004 - 01/2002
5P-SelectinIBA
10/2004 - 01/2002
5Rosiglitazone (Avandia)FDA Link
05/2004 - 09/2003
5Interleukin-1beta (Interleukin 1 beta)IBA
03/2004 - 01/2002
5Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2004 - 01/2002
4EnzymesIBA
06/2017 - 01/2002
4Glycogen Synthase (Synthase I)IBA
02/2007 - 05/2006
4Glycogen Synthase Kinase 3 betaIBA
01/2007 - 09/2005
4Alanine Transaminase (SGPT)IBA
05/2006 - 03/2004
4Arachidonate 5-Lipoxygenase (5 Lipoxygenase)IBA
10/2004 - 06/2003
4AmylasesFDA Link
05/2004 - 05/2002
4CeruletideIBA
05/2004 - 05/2002
3AcidsIBA
03/2022 - 07/2002
3Collagen Type II (Type II Collagen)IBA
07/2006 - 10/2002
3Interleukin-6 (Interleukin 6)IBA
05/2006 - 06/2002
3Creatine Kinase (Creatine Phosphokinase)IBA
09/2005 - 03/2004
3Indicators and Reagents (Reagents)IBA
09/2005 - 03/2004
3TransferasesIBA
09/2004 - 08/2002
3Transcription Factors (Transcription Factor)IBA
08/2004 - 01/2002
3NF-kappa B (NF-kB)IBA
08/2004 - 01/2002
3PPAR-gamma AgonistsIBA
05/2004 - 01/2004
33-nitrotyrosineIBA
05/2004 - 05/2002
3DinitrobenzenesIBA
04/2004 - 07/2002
3GW 274150IBA
03/2004 - 10/2002
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2004 - 02/2003
3SuspensionsIBA
02/2004 - 10/2002
3Malondialdehyde (Propanedial)IBA
09/2003 - 02/2003
3Peroxidase (Myeloperoxidase)IBA
09/2003 - 02/2003
3ProstaglandinsIBA
01/2003 - 05/2002
3Nitric Oxide Synthase (NO Synthase)IBA
01/2003 - 05/2002
3Poly(ADP-ribose) Polymerase InhibitorsIBA
07/2002 - 01/2002
3Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
07/2002 - 01/2002
2PolyphenolsIBA
03/2022 - 01/2012
2AntioxidantsIBA
03/2022 - 07/2003
2Glycogen Synthase KinasesIBA
02/2007 - 01/2007
2Insulin (Novolin)FDA Link
02/2007 - 05/2006
24- benzyl- 2- methyl- 1,2,4- thiadiazolidine- 3,5- dioneIBA
07/2006 - 05/2006
2EmulsionsIBA
07/2006 - 10/2002
2Freund's AdjuvantIBA
07/2006 - 10/2002
2Interleukin-10 (Interleukin 10)IBA
05/2006 - 07/2002
2BilirubinIBA
09/2004 - 03/2004
2imisopasem manganeseIBA
08/2004 - 08/2002
2Superoxide DismutaseIBA
08/2004 - 01/2004
2Superoxides (Superoxide)IBA
08/2004 - 01/2004
2Sulfonic AcidsIBA
04/2004 - 07/2002
22,4-dinitrofluorobenzene sulfonic acidIBA
04/2004 - 02/2003
2Reactive Oxygen Species (Oxygen Radicals)IBA
01/2004 - 10/2002
2InterleukinsIBA
09/2003 - 08/2002
2GPI 6150IBA
07/2002 - 03/2002
2DNA (Deoxyribonucleic Acid)IBA
07/2002 - 01/2002
1Biological ProductsIBA
03/2022
1Messenger RNA (mRNA)IBA
03/2022
1Proteins (Proteins, Gene)FDA Link
03/2022
1Waste Products (Waste Product)IBA
03/2022
1Interleukin-8 (Interleukin 8)IBA
03/2022
1TanninsIBA
03/2022
1PhytochemicalsIBA
03/2022
1FlavonoidsIBA
03/2022
1Oxidoreductases (Dehydrogenase)IBA
03/2020
1thiazolyl blueIBA
03/2020

Therapy/Procedure

11Therapeutics
01/2015 - 01/2002
3Intraperitoneal Injections
05/2004 - 05/2002